Skip to main content
Premium Trial:

Request an Annual Quote

Small Business Grants to Fund Proteomics Tools

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health wants to spur development of new proteomics and glycomics technologies and has started a program to award small businesses grants for new tools that involve biology, analytical chemistry, and informatics.

The field of proteomics is expanding and evolving rapidly, and new technologies are needed to meet the needs of the academic and commercial research and clinical proteomics fields, NIH said in a request for proposals. These grants are aimed at funding small firms interested in or involved in developing new tools in these areas.

Funded through the Small Business Innovation Research (SBIR) program, these grants from the National Center for Research Resources and other NIH institutes will provide up to $350,000 for Phase I and $600,000 for Phase II grants.

The SBIR and Small Business Technology Transfer grants will fund proteomics and glycomics projects in a range of specific areas including robotics; sample preparation; mass spectrometry; gel and array imaging; quantitation; automated data acquisition, and others.

"The application of proteomics tools in the clinical setting lags far behind their use in basic science and drug discovery," NIH stated in the funding announcement. "Though this is not due solely to technological constraints, the unique challenges associated with development of simple, rapid, and robust technologies for the clinic demand a somewhat different perspective than might be taken in consideration of a purely research-driven project."

NIH said that it has not set a number for how many of these grants it will award.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.